69.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
How To Trade (SLNO) - news.stocktradersdaily.com
Soleno Therapeutics appoints CBIZ CPAs as new auditor By Investing.com - Investing.com Nigeria
Soleno Therapeutics appoints CBIZ CPAs as new auditor - Investing.com Australia
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Soleno launches Vykat XR (SLNO:NASDAQ) - Seeking Alpha
Soleno Therapeutics launches FDA-approved PWS treatment By Investing.com - Investing.com South Africa
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved - MSN
Soleno Therapeutics launches FDA-approved PWS treatment - Investing.com
Soleno Therapeutics Announces VYKAT(TM) XR Launch - GlobeNewswire
Breakthrough PWS Treatment VYKAT XR Now Available: First-Ever FDA Approval for Rare Disease - Stock Titan
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN
KLP Kapitalforvaltning AS Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Soleno Therapeutics (SLNO) Gains FDA Approval for Prader-Willi T - GuruFocus
SLNO Quantitative Stock Analysis - Nasdaq
Capnia Inc stock soars to 52-week high, hits $74 mark - Investing.com
Soleno therapeutics SVP sells $265,156 in stock By Investing.com - Investing.com Australia
Soleno therapeutics SVP sells $265,156 in stock - Investing.com
Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Bhatnagar Anish Sells 699,095 Shares - MarketBeat
Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod By Investing.com - Investing.com South Africa
Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod - Investing.com
High Growth Tech Stocks To Watch In The US April 2025 - simplywall.st
Soleno Therapeutics CEO sells $35.3 million in stock By Investing.com - Investing.com Philippines
Soleno Therapeutics CEO sells $35.3 million in stock - Investing.com Australia
Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock - Investing.com Australia
Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock By Investing.com - Investing.com Nigeria
Soleno Therapeutics exec sells shares worth $9.5 million By Investing.com - Investing.com South Africa
Soleno therapeutics director Matthew Pauls sells $424,797 in stock By Investing.com - Investing.com Canada
Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock - Investing.com India
Soleno therapeutics director Matthew Pauls sells $424,797 in stock - Investing.com Australia
Soleno Therapeutics exec sells $700,330 in stock - Investing.com India
Soleno Therapeutics CFO sells $4.88 million in stock - Investing.com Australia
Soleno Therapeutics Executives and Director Sell Shares - TradingView
Soleno Therapeutics CCO sells shares worth $2.48m - Investing.com
Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock By Investing.com - Investing.com UK
Soleno Therapeutics CCO sells shares worth $2.48m By Investing.com - Investing.com UK
Soleno Therapeutics CFO sells $4.88 million in stock By Investing.com - Investing.com UK
Soleno Therapeutics Executives Sell Shares - TradingView
Soleno Therapeutics exec sells shares worth $9.5 million - Investing.com
Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock - Investing.com Australia
Soleno stock price target raised to $100 at H.C. Wainwright By Investing.com - Investing.com South Africa
Soleno stock price target raised to $100 at H.C. Wainwright - Investing.com
Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock By Investing.com - Investing.com South Africa
Soleno Therapeutics Stock (SLNO) Surges on FDA Green Light for PWS Treatment - Markets Insider
Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week? - Insider Monkey
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):